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A tetrapeptide Arg-Gly-Asp-Ser (RGDS) has been 
shown to be a versatile  cell recognition signal of extra- 
cellular matrix components for the interaction with 
cells. We introduced the RGDS tetrapeptide into a 
truncated form of protein A, a staphylococcal immu- 
noglobulin-binding protein, by inserting  an oligonucle- 
otide  cassette encoding the tetrapeptide into the coding 
region  of the protein A expression  vector pRIT2T. The 
mutagenized protein was capable of not only binding 
to immunoglobulin G but also mediating cell attach- 
ment and spreading onto an inert substrate. Cell adhe- 
sion mediated by the mutagenized protein was inhib- 
itable by a synthetic peptide Gly-Arg-Gly-Asp-Ser but 
not by a related peptide Gly-Arg-Gly-Glu-Ser, con- 
firming that the inserted RGDS tetrapeptide served as 
a recognition signal for cell adhesion. Furthermore, 
the RGDS-containing protein was capable of adhering 
cells onto an immunoglobulin-coated surface which 
could not by itself support cell adhesion. Thus, the  cell 
adhesive and immunoglobulin binding activities  of  the 
mutagenized protein appear to function coordinately. 
The protocol described here is essentially applicable to 
any protein and, therefore, provides a general princi- 
ple in tailoring  novel multifunctional proteins having 
cell  adhesive  activity. 
The interaction of cells with the extracellular  matrix com- 
ponents plays an  important role in many biological processes 
such as cell migration, differentiation, and possibly prolifer- 
ation. Recently, a family of proteins capable of mediating cell 
adhesion onto biologic as well as artificial substrates  has been 
isolated from the extracellular matrix and body fluids (for 
recent reviews, see Refs. 1-4). These cell adhesive proteins, 
characterized by the presence of a conserved tripeptide Arg- 
Gly-Asp (RGD), include fibronectin (5), vitronectin (6), lam- 
inin ( 7 ) ,  von Willebrand factor (8), type I collagen (9), fibrin- 
ogen (lo), thrombospondin (ll), osteopontin (12), and  ten- 
ascin (13). The RGD sequence serves as a recognition signal 
for the interaction  with cell surface receptor molecules, col- 
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lectively termed  integrins (3, 14). 
In  the present investigation, we attempted  to genetically 
engineer an artificial cell adhesive protein by insertion of the 
Arg-Gly-Asp-Ser (RGDS) tetrapeptide, the minimal cell ad- 
hesive sequence of fibronectin (5), into a truncated form of 
the bacterial IgG-binding protein,  protein A’.’  We report here 
that  the modified bacterial  protein was capable of binding not 
only to IgG but also to  the RGD-directed cell surface recep- 
tor(s), thereby serving as a mediator of cell adhesion onto  the 
substrate coated with IgG. 
EXPERIMENTAL  PROCEDURES 
Oligonucleotide Synthesis-Oligonucleotides were chemically syn- 
thesized using an Applied Biosystems DNA synthesizer model 380A 
(Foster City, CA). The double-stranded DNA oligomer encoding a 
heptapeptide SLRGDSA (“RGDS cassette”) was obtained by anneal- 
ing 5’AGCTTACGTGGTGATAGCGCT3’ and 5’AGCTAGCGCT- 
ATCACCACGTA3’ (Fig. 1). Another double-stranded DNA  oligomer 
encoding SLRGESA (“RGES cassette”) was prepared by annealing 
5’AGCTTACGTGGTGAAAGCGCT3‘ and 5’AGCTAGCGCTTTC- 
ACCACGTA3’. 
Vector Constructions-Aplasmid expression vector pRIT2T  (Phar- 
macia, Uppsala, Sweden) was partially digested with HindIII (Takara 
Shuzo, Kyoto, Japan),  and  the linearized plasmid was ligated with 
>1000-fold molar excess of the unphosphorylated oligonucleotide 
cassette and used to transform Escherichia coli HB101. The plasmid 
containing the cassette at  the downstream HindIII  site was selected 
upon double digestion with NheI and PstI, by which the desired 
construct gave rise to a 385-base pair fragment. The  pRIT2T deriv- 
ative was used to transform E. coli N4830 to express the RGDS- or 
RGES-containing protein under the control of the temperature- 
sensitive X repressor (15). 
Protein Purification-The E. coli N4830 harboring pRIT2T or its 
derivative was  grown in  LB medium containing 50 pg/ml ampicillin 
at 30 “C until ODmnm became approximately 1.0. The temperature 
of the culture was then shifted to 42 “C by adding an equal volume of 
LB medium preheated to 54 “C. Bacterial cells were cultured at  42 “C 
for 90 min and  then harvested by centrifugation at 5,000 X g. The 
cells were suspended in 0.1 volume of TS (50 mM Tris buffer, pH 7.6, 
containing 150 mM NaCl) and lysed by sonication. The lysate was 
centrifuged at 20,000 x g for 20 min at 4  “C, and  the  supernatant was 
applied to a IgG-Sepharose column (Pharmacia)  after dilution with 5 
volumes of TS. After extensive washing with TS,  the bound protein 
was eluted with 0.5 M ammonium acetate,  pH 3.4, and dialyzed against 
2 mM CAPS’ buffer, pH 10.5, containing 0.5 mM EDTA at 4  “C. The 
protein concentration was estimated from the absorbance at 280 nm 
assuming that  the absorption coefficient of 0.1% protein A‘ is 0.38 
cm”. Purity of the modified proteins thus obtained was verified by 
SDS-PAGE using 10% acrylamide gels, followed by staining with 
Coomassie  Blue. 
Protein Sequencing-Protein A’ mutagenized with the RGDS cas- 
sette was cleaved at room temperature with CNBr in 70% formic acid 
as described by Gross (16). The fragment containing the RGDS 
sequence was isolated by reversed-phase HPLC on a column of 
SynChropak RP8 (4.1 X 250 mm, SynChrom, Lafayette, IN). Auto- 
mated sequence analysis of the purified fragment was performed with 
an Applied Biosystems protein sequenator model 470A (Foster City, 
CA). 
Cell Adhesion  Assay-The cell adhesive activity of the mutagenized 
- 
The truncated form of protein A encoded by the protein A 
expression vector pRIT2T is referred to  as “protein A”’ in this paper 
to distinguish it from the  intact protein. 
The abbreviations used are: CAPS, 3-(cyclohexylamino)propane- 
sulfonic acid; HPLC, high performance liquid chromatography; SDS- 
PAGE, polyacrylamide gel electrophoresis in the presence of sodium 
dodecyl sulfate; Hepes, N-2-hydroxyethylpiperazine-N’-2-ethanesul- 
fonic acid. 
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protein A's was determined  essentially  as previously described (17, 
18). Twenty-four-well bacteriological plates  (Petray  SH-T24FS,  Ter- 
umo,  Tokyo,  Japan) were coated  with the modified protein A' upon 
appropriate  dilutions with 0.1 M NaHC03,  pH 9.5, overnight a t  room 
temperature  and  then blocked  with 0.1% bovine serum  albumin for 2 
h. The baby hamster kidney fibroblasts were detached from the 
culture dish  with 0.25% trypsin  and 0.02% EDTA, washed  once  with 
adhesion  medium (a 1:l mixture of Dulbecco's modified Eagle's 
medium and Hepes-buffered saline  (20 mM Hepes, 137 mM NaCI, 3 
mM KCI, pH 7.1)) containing 0.01% soybean trypsin inhibitor and 
twice with adhesion medium without the inhibitor. The cells were 
incubated  on  the  precoated  polystyrene  plates a t  4 X lo5 cells/well 
for 60 min in adhesion medium a t  37  "C  and  then gently  washed three 
times with adhesion medium. The  attached cells were fixed with 4% 
formaldehyde and photographed using phase contrast microscopy. 
The  number of cells adopting well spread morphology  was counted 
with  four independent fields/well. 
Protein Adsorption  Isotherms-The amount of proteins  adsorbed 
onto plastic substrate was determined using 1251-labeled proteins. 
Protein iodination  was  performed by the  chloramine-T  method (34). 
The 24-well plastic plates were coated  with serially diluted  protein 
solutions as described for the cell adhesion assay, except that  the 
protein  solutions  contained a trace  amount of the  iodinated  protein. 
The  plates were washed three  times  with  phosphate-buffered  saline 
(8.1 mM Na2HP04, 1.5 mM KH2P04, 137 mM NaC1,2.7 mM KCI, pH 
7.4), and  then  the radioactivity adsorbed  on  each well (2 cm2/well) 
was determined with  a  well-type y counter (Aloka  ASP-120,  Aloka, 
Tokyo,  Japan). 
RESULTS AND DISCUSSION 
A plasmid vector pRIT2T encodes a truncated form of 
protein A  (residues 23-269), hereafter referred to as protein 
A', which contains four  consecutive IgG-binding  domains (15, 
19).  There  are two HindIII  sites  within  the coding region of 
the plasmid, of which the  downstream  site was chosen for the 
insertion of the oligonucleotide cassette encoding either 
SLRGDSA or SLRGESA heptapeptide (Fig. 1). The  amino 
acid  residues flanking  the  RGDS  or  RGES  tetrapeptide  are 
encoded by the  HindIII  linkers  attached  to  the oligonucleo- 
tides encoding these  tetrapeptides.  The  double-stranded oli- 
gonucleotides contain a unique  NheI  site at the 3' end which 
facilitates  the  identification of the  construct  containing  the 
insert at the  correct  HindIII  site  with a right  orientation.  The 
expression of the mutagenized protein was  induced  by heat 
inactivation of the  temperature-sensitive X repressor of the 
host E. coli. 
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FIG. 1. Construction of the plasmid vector PAD-1 by inser- 
tion of an oligonucleotide cassette encoding SLRGDSA. Re- 
striction  sites  indicated  are: H ,  HindIII; P, PstI; E,  EcoRI; N ,  NheI. 
since they could bind to an IgG-Sepharose  column. The 
mutagenized proteins  migrated slightly  above the unmodified 
protein upon SDS-PAGE (Fig. 2 A ) ,  in agreement with the 
insertion of the extra heptapeptide, either SLRGDSA or 
SLRGESA. This was further confirmed by direct protein 
sequencing of the CNBr-cleaved fragment containing the 
SLRGDSA  heptapeptide (Fig. 2B). 
Fig. 3  shows the cell adhesive activity of the mutagenized 
protein.  The  protein A' containing  the  RGDS sequence  was 
capable of mediating cell attachment  and  subsequent  spread- 
ing when coated  on  the  inert  plastic surface (panel C), al- 
though  the unmodified protein A' was totally inactive (panel 
B ) .  Substitution of aspartic acid with glutamic acid in the 
extra heptapeptide completely abolished the cell adhesive 
activity of the modified protein (panel D). Thus, acquisition 
of the cell adhesive activity by protein A' strictly  requires  the 
RGD sequence and  is  not simply due  to  the  insertion of the 
extra  heptapeptide.  The specificity of the cell adhesive activity 
of the modified protein was further confirmed by inhibition 
experiments  with  synthetic  pentapeptides. Cell adhesion  onto 
the  substrate  coated  with  the  protein A' containing  the  RGDS 
sequence  was  completely inhibited by GRGDS (panel E )  but 
not by GRGES (panel F ) .  
Although the  protein A' with  the  RGDS sequence  displayed 
a significant cell adhesive activity, it was less active than 
intact  fibronectin (Fig. 4). The  maximal evel of cell spreading 
achieved  was  only  half as  much  as  that chieved  by  fibronec- 
tin.  The difference in  the cell adhesive activity between these 
two  proteins was not  due  to  the difference in  the  amounts of 
the  proteins  adsorbed  on  plastic  substrate,  since more modi- 
fied protein A' than  fibronectin was adsorbed  on  the  substrate 
at  the  protein  concentrations where  significant cell spreading 
was  observed (Fig. 4, inset). It  is likely that  the  affinity of the 
RGDS cell adhesion  signal  with  the c ll surface receptors was 
21.5" 
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FIG. 2. SDS-PAGE and partial amino acid sequencing of 
protein A's modified by insertion of extra heptapeptides. A, 
SDS-PAGE of control  protein A' (lane I ) ,  protein A' mutagenized 
with the  RGDS  cassette  (lane 2), and  protein A' mutagenized  with 
the  RGES  cassette  (lune 3 ) .  Positions of the molecular weight stand- 
ards  are shown in  the left margin. B, partial  amino acid  sequence of 
the  CNBr  fragment of the  protein A' mutagenized with  the  RGDS 
cassette. The  CNBr  fragment of the modified protein  containing  the 
extra heptapeptide was isolated by HPLC and sequenced with an 
automated  protein  sequenator. 
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FIG. 3. Cell  adhesive  activities of protein A's mutagenized 
by  inser t ion of ext ra   heptapept ides .  Trypsinized baby hamster 
kidney  fibroblasts were incubated  on  the  plastic  substrates  precoated 
with the following proteins a t  5 pg/ml: A ,  fibronectin; B ,  control 
protein A'; C ,  E, and F, protein A' containing  the  extra  SLRGDSA 
peptide; D, protein A' containing  the  extra  SLRGESA peptide. The 
synthetic  pentapeptide  GRGDS ( E )  or GRGES ( F )  was  included in 
the  adhesion medium in order to examine  its  inhibitory effects on  the 
cell adhesion  onto  the  substrate  coated with protein A' containing 
the  SLRGDSA peptide. Bar = 100 pm. 
significantly lower when transplanted in protein A' than 
situated  at  the original locus in  intact fibronectin. 
Since  the  protein A' with  the  RGDS sequence  was capable 
of not only binding  to IgG but  also of being recognized by the 
RGD-directed cell surface receptors, we examined whether 
the modified protein could serve as  an  adaptor for the  inter- 
action of the  RGD-directed  receptors  with IgG. Although the 
cells could not  adhere  to  the  substrate  coated  with IgG (Fig. 
5 A ) ,  they could attach  and  spread  on  the  same  substrate  after 
pretreatment with protein A' containing  the  RGDS sequence 
(Fig. 5C). Pretreatment  with  the unmodified protein (Fig. 5 B )  
or the  protein  containing  the  RGES sequence (Fig. 5 0 )  did 
not allow the cells to  attach.  These  results clearly demonstrate 
that  the cell adhesive and IgG binding  activities of the  RGDS- 
containing protein A' function coordinately. It should be 
noted, however, that the RGDS-containing protein A' ad- 
sorbed on the substrate via IgG was less active than that 
adsorbed  directly (compare Fig. 5C with Fig. 3C). This could 
be due  to  either  partial b ockade or conformational  change of 
the  RGDS signal  upon binding  to  the  substrate-adsorbed IgG. 
A computer  search of the  protein sequence data  base  has 
identified more than 100 different proteins containing the 
RGD  tripeptide,  many of which are unlikely to possess the 
cell adhesive  activity (3,20). Indeed,  no  significant  affinity  to 
the RGD-directed cell surface receptors has been detected 
with IgG (Ref. 21; also the  present  study) or a peptide derived 
from epidermal growth factor receptor (22), both of which 
contain  the RGD  sequence. Thus,  the presence of the  RGDS 
sequence per se does not  guarantee  the coincidence of the cell 
adhesive activity. I t  is likely that, besides being exposed to 
P I  I 
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FIG. 4. Quanti ta t ive cell spreading assay on the substrates  
coated wi th  the mutagenized protein A's. The plastic substrates 
were coated  with different  concentrations of fibronectin (O), control 
protein A' (A), protein A' containing  the  RGDS sequence (O), and 
protein A' containing  the  RGES sequence (0). Cells were incubated 
on  the  substrates for 60 min  in a COZ incubator.  The  extent of cell 
spreading was  expressed as  the  number of cells adhered  to  unit surface 
area (i.e. cm'). The  concentration of fibronectin  is expressed as  that 
of fibronectin  monomer  in  order to compare  the cell adhesive  activity 
of fibronectin  and  the mutagenized protein A' on a  "per RGDS site" 
basis. Znset shows the adsorption isotherm of fibronectin and the 
RGDS-containing  protein A'. 
FIG. 5. Cell adhesion on to  the substrates  precoated with 
IgG.  The plastic substrates were first  coated  with  human IgG (200 
pg/ml) and then blocked with 0.1% bovine serum albumin. The 
substrates were incubated  with  phosphate-buffered  saline ( A ) ,  control 
protein A', 5 pg/ml ( B ) ,  protein A' containing  the  SLRGDSApeptide, 
5 pg/ml ( C ) ,  or protein A' containing the SLRGESA peptide (D) 
before incubation with trypsinized cells. Bar = 100 pm. 
the  surface of the molecule, the  RGD(S) sequence must  as- 
sume a certain conformation to be recognized by its cell 
surface receptors with an  affinity sufficient for stable cell 
adhesion (3,  23). 
In  the  present  investigation, we have  shown that  the  inser- 
tion of the  RGDS sequence into  one of the four  IgG-binding 
domains of protein A' confers  the cell adhesive activity to 
this bacterial protein. Based on the x-ray crystallographic 
analysis of the IgG-binding domain of protein A complexed 
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with the Fc fragment of IgG (24), it is predicted that the 
RGDS sequence is inserted  to  one of the two anti-parallel cy- 
helices composing the framework of the IgG-binding domain 
and is exposed at  the  surface of the molecule. Furthermore, 
prediction of the secondary structure by the algorithm of 
Chou and Fasman (25) suggests that the RGDS sequence 
within protein A’ is likely to  assume a p-turn  conformation, 
as considered to be the case within  intact fibronectin. Thus, 
it is not irrational to speculate that the inserted RGDS 
tetrapeptide  assumes a conformation recognizable by the cell 
surface receptors with  an  affinity enough to  support  stable 
cell adhesion. 
I t  should  be noted, however, that  the  affinity of the modified 
protein A’ to the RGD-directed receptors was significantly 
lower than  that of intact  fibronectin.  This  is  most likely due 
to  the incomplete fitness of the  RGDS  signal  with  its  receptors 
when situated  as a “transplant”  in  the foreign protein.  The 
reduced activity of the  RGDS signal of the modified protein 
could be also  partly  due  to  the lack of the  putative second 
signal  required  for the full cell adhesive activity (26). The cell 
adhesive protein A’ described in this paper will provide a 
suitable  experimental  system for identification  and localiza- 
tion of the putative second signal by simply inserting the 
candidate sequence alone or together  with  the  RGDS signal 
into  protein A’. 
The RGD cell recognition signal of many cell adhesive 
proteins  has been  shown to be recognized by a family of cell 
surface receptor molecules, termed  integrins (3, 14). It  is of 
real  interest,  therefore, which integrin(s) is involved in  the 
cell adhesion mediated by the  RGDS-containing  protein A’. 
Recently,  Singer et al. (35) reported  that  both  fibronectin  and 
vitonectin receptors became concentrated at  focal contacts 
when cells spread  out  on  the  substrate  coated  with  the  syn- 
thetic  RGDS  peptide-albumin conjugate,  suggesting that  both 
receptors can recognize the  synthetic peptide.  Although these 
observations  cannot be  simply extended  to  the cell adhesion 
mediated by the mutagenized protein A’, both  receptors may 
also be involved in  the cell adhesion  mediated by the  muta- 
genized protein. 
Recent  advances  in genetic engineering  make it possible to 
introduce essentially any desired mutation  to a protein. TO 
date, most of the interest in protein engineering has been 
focused on the modification of the specificity and/or the 
affinity of enzymes to  their  substrates (27-29) as well as their 
stability  under nonphysiological conditions (30-32). However, 
the  strict  requirements of the  three-dimensional  structure of 
enzymes  for their  catalytic  activities  make  it  extremely dlffi- 
cult to transplant the catalytic site of an  enzyme to other 
proteins  without losing its activity. In  contrast,  the cell ad- 
hesive activity associated with  the  RGD-containing  proteins 
can be partly, although not fully, reproduced by a short 
synthetic peptide or a small cell-binding fragment (5 ,  33). 
This  unique  feature of these cell adhesive proteins offers an 
excellent model for “active site transplantation” by inser- 
tional  mutation.  The technology  described here is essentially 
applicable to any protein and allows us to design a wide 
variety of artificial cell adhesive proteins possibly without 
destroying their intrinsic biological activities. These man- 
made multifunctional  proteins may  be  useful in  modulating 
cell-to-cell and cell-to-substrate interactions during tissue 
remodeling, platelet aggregation, and possibly tumor  metas- 
tasis. 
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